Eliot Forster, Ph.D.

Eliot Forster joined Immatics' Board of Directors in September 2020. Eliot Forster, Ph.D., has almost three decades of experience in the pharmaceutical and biotechnology industry. He is Chief Executive officer of F-star Therapeutics and is non-executive Chairman of Avacta plc. He has previously served as Chief Executive Officer of Immunocore Ltd, Creabilis Therapeutics and Solace Pharmaceuticals Inc. Other previous roles include Head of Development and Operations for the EU and Asia at Pfizer and founding Chairman of MedCity. He is an honorary visiting Professor of Molecular and Clinical Cancer Medicine at the University of Liverpool and an honorary international visiting Professor at the University of Pavia. He is also Board member of OSCHR (Office for Strategic Coordination of Health Research), and the National Genomics Board. Forster holds a PhD from University of Liverpool and an MBA from Henley Management College.